291 related articles for article (PubMed ID: 22767499)
1. Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection.
Papadantonakis N; Matsuura S; Ravid K
Blood; 2012 Aug; 120(9):1774-81. PubMed ID: 22767499
[TBL] [Abstract][Full Text] [Related]
2. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase.
Eliades A; Papadantonakis N; Bhupatiraju A; Burridge KA; Johnston-Cox HA; Migliaccio AR; Crispino JD; Lucero HA; Trackman PC; Ravid K
J Biol Chem; 2011 Aug; 286(31):27630-8. PubMed ID: 21665949
[TBL] [Abstract][Full Text] [Related]
3. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms.
Tadmor T; Bejar J; Attias D; Mischenko E; Sabo E; Neufeld G; Vadasz Z
Am J Hematol; 2013 May; 88(5):355-8. PubMed ID: 23494965
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide.
Eliades A; Papadantonakis N; Matsuura S; Mi R; Bais MV; Trackman P; Ravid K
Cell Cycle; 2013 Apr; 12(8):1242-50. PubMed ID: 23518500
[TBL] [Abstract][Full Text] [Related]
5. Normal and malignant megakaryopoiesis.
Wen Q; Goldenson B; Crispino JD
Expert Rev Mol Med; 2011 Oct; 13():e32. PubMed ID: 22018018
[TBL] [Abstract][Full Text] [Related]
6. Human megakaryocyte production: cell biology and clinical considerations.
Gewirtz AM; Hoffman R
Hematol Oncol Clin North Am; 1990 Feb; 4(1):43-64. PubMed ID: 2179214
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of lysyl oxidase and adhesion to collagen of human megakaryocytes and platelets in primary myelofibrosis.
Abbonante V; Chitalia V; Rosti V; Leiva O; Matsuura S; Balduini A; Ravid K
Blood; 2017 Aug; 130(6):829-831. PubMed ID: 28592432
[No Abstract] [Full Text] [Related]
8. Megakaryocytes and platelets in myeloproliferative disorders.
Briere J; Kiladjian JJ; Peynaud-Debayle E
Baillieres Clin Haematol; 1997 Feb; 10(1):65-88. PubMed ID: 9154316
[TBL] [Abstract][Full Text] [Related]
9. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.
Guo BB; Allcock RJ; Mirzai B; Malherbe JA; Choudry FA; Frontini M; Chuah H; Liang J; Kavanagh SE; Howman R; Ouwehand WH; Fuller KA; Erber WN
Am J Pathol; 2017 Jul; 187(7):1512-1522. PubMed ID: 28502479
[TBL] [Abstract][Full Text] [Related]
11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
12. Platelet peroxidase deficiency in a case of myelodysplastic syndrome with myelofibrosis.
Imbert M; Jarry MT; Tulliez M; Breton-Gorius J
J Clin Pathol; 1983 Nov; 36(11):1223-8. PubMed ID: 6630573
[TBL] [Abstract][Full Text] [Related]
13. [Megakaryocytopoiesis in myeloproliferative disorders].
Podolak-Dawidziak M
Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
[No Abstract] [Full Text] [Related]
14. Acute myelofibrosis.
Rupani M
Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological mechanisms operating in the development of myelofibrosis: role of megakaryocytes.
Castro-Malaspina H; Moore MA
Nouv Rev Fr Hematol (1978); 1982; 24(4):221-6. PubMed ID: 6292827
[TBL] [Abstract][Full Text] [Related]
16. Acute myelofibrosis--a leukemia of pluripotent stem cell. A report of three cases and review of the literature.
Amberger DM; Saleem A; Kemp BL; Truong LD
Ann Clin Lab Sci; 1990; 20(6):409-14. PubMed ID: 2073090
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components.
Castro-Malaspina H
Prog Clin Biol Res; 1984; 154():427-54. PubMed ID: 6089232
[TBL] [Abstract][Full Text] [Related]
18. Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice.
Leiva O; Ng SK; Matsuura S; Chitalia V; Lucero H; Findlay A; Turner C; Jarolimek W; Ravid K
Int J Hematol; 2019 Dec; 110(6):699-708. PubMed ID: 31637674
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
Zankovich R; Thiele J; Fischer R; Diehl V
Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
[No Abstract] [Full Text] [Related]
20. Lysyl oxidase inhibition in primary myelofibrosis: A renewed strategy.
Piasecki A; Leiva O; Ravid K
Arch Stem Cell Ther; 2020 Dec; 1(1):23-27. PubMed ID: 33738462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
